| Norris Medicines Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524414 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE744C01029 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -15.07 |
Market Cap(₹Cr) : 15.33 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.92 | 1.41 | 3.27 | 2.00 | 1.46 | 2.72 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.92 | 1.41 | 3.27 | 2.00 | 1.46 | 2.72 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.02 | 0.00 | 0.00 | 0.02 | 0.05 |
| Total Income | 0.92 | 1.43 | 3.27 | 2.00 | 1.48 | 2.77 |
| Total Expenditure | 1.21 | 1.10 | 2.32 | 2.49 | 1.56 | 2.65 |
| PBIDT | -0.28 | 0.33 | 0.95 | -0.49 | -0.08 | 0.12 |
| Interest | 0.00 | 0.15 | 0.13 | 0.11 | 0.11 | 0.15 |
| PBDT | -0.28 | 0.17 | 0.82 | -0.60 | -0.19 | -0.03 |
| Depreciation | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 | 0.14 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Reported Profit After Tax | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 | -0.23 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 | -0.23 |
| EPS (Unit Curr.) | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 | -0.23 |
| EPS (Adj) (Unit Curr.) | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 | -0.23 |
| Calculated EPS (Unit Curr.) | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 | -0.23 |
| Calculated EPS (Adj) (Unit Curr.) | -0.40 | 0.05 | 0.70 | -0.72 | -0.31 | -0.23 |
| Calculated EPS (Ann.) (Unit Curr.) | -1.60 | 0.20 | 2.81 | -2.89 | -1.25 | -0.92 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -1.60 | 0.20 | 2.81 | -2.89 | -1.25 | -0.92 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -30.43 | 23.40 | 29.05 | -24.50 | -5.48 | 4.41 |
| PBDTM(%) | -30.43 | 12.06 | 25.08 | -30.00 | -13.01 | -1.10 |
| PATM(%) | -43.48 | 3.55 | 21.41 | -36.00 | -21.23 | -8.46 |
